trial · primary record
Alenia® 12mcg + 400mcg / Alenia® 6mcg + 200mcg
Asthma Copd
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 472 |
| Primary completion | 2024-10-30 |
| Primary endpoint | FEV1 |
| Registry ID | NCT04233190 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:15.711Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04233190
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.